Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Yoshihara

Showing results (21-30 of 144) with videos related to

Pageof 15
Sort By:
Ejhaem|June 8, 2026
Early Transplantation After Pretransplant Reduction of <i>TP53</i>-Altered Clones and Prolonged Dose-Adjusted Azacitidine Maintenance: A Three-Case SeriesFuyuki Yamagata, Kyoko Yoshihara, Yasuhito Nannya, et al.
Hemasphere|August 16, 2021
High Prevalence of PNH-phenotype Cells in Patients Who Received CD19-targeted CAR T-cell TherapyKyoko Yoshihara, Ikuo Matsuda, Nobuto Utsunomiya, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 12, 2011
Impaired physiological function and health-related QOL in patients before hematopoietic stem-cell transplantationShinichiro Morishita, Katsuji Kaida, Kazuhiro Ikegame, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 2, 2015
Host Foxp3+CD4+ Regulatory T Cells Act as a Negative Regulator of Dendritic Cells in the Peritransplantation PeriodTakayuki Inoue, Kazuhiro Ikegame, Katsuji Kaida, et al.
Ejhaem|July 18, 2022
T-cell lymphoma, B-cell lymphoma, and myelodysplastic syndrome harboring common mutations: Trilineage tumorigenesis from a common founder cloneKyoko Yoshihara, Yasuhito Nannya, Ikuo Matsuda, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 2026
[XMEN disease diagnosed following persistent Epstein-Barr virus viremia and recurrent lymphadenopathy]Ryo Ikunari, Kyoko Yoshihara, Ikuo Matsuda, et al.
Journal of Molecular Biology|January 16, 2003
Purification, characterization, and gene expression of all sigma factors of RNA polymerase in a cyanobacteriumSousuke Imamura, Satoshi Yoshihara, Serina Nakano, et al.
European Radiology|March 23, 2019
Early evaluation of tumor response to <sup>90</sup>Y-ibritumomab radioimmunotherapy in relapsed/refractory B cell non-Hodgkin lymphoma: what is the optimal timing for FDG-PET/CT?Kazuhiro Kitajima, Masaya Okada, Toru Kashiwagi, et al.
Annals of Hematology|March 4, 2020
Treatment strategy in a patient showing borderline features between plasmablastic lymphoma and plasmablastic myeloma harboring a 17p deletionKyoko Yoshihara, Satoshi Yoshihara, Ikuo Matsuda, et al.
International Journal of Hematology|February 1, 2011
Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL geneMasaya Okada, Atsushi Satake, Katsuji Kaida, et al.
Pageof 15

Showing results (21-30 of 144) with videos related to

Sort By:
Pageof 15
Ejhaem|June 8, 2026
Early Transplantation After Pretransplant Reduction of <i>TP53</i>-Altered Clones and Prolonged Dose-Adjusted Azacitidine Maintenance: A Three-Case SeriesFuyuki Yamagata, Kyoko Yoshihara, Yasuhito Nannya, et al.
Hemasphere|August 16, 2021
High Prevalence of PNH-phenotype Cells in Patients Who Received CD19-targeted CAR T-cell TherapyKyoko Yoshihara, Ikuo Matsuda, Nobuto Utsunomiya, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 12, 2011
Impaired physiological function and health-related QOL in patients before hematopoietic stem-cell transplantationShinichiro Morishita, Katsuji Kaida, Kazuhiro Ikegame, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 2, 2015
Host Foxp3+CD4+ Regulatory T Cells Act as a Negative Regulator of Dendritic Cells in the Peritransplantation PeriodTakayuki Inoue, Kazuhiro Ikegame, Katsuji Kaida, et al.
Ejhaem|July 18, 2022
T-cell lymphoma, B-cell lymphoma, and myelodysplastic syndrome harboring common mutations: Trilineage tumorigenesis from a common founder cloneKyoko Yoshihara, Yasuhito Nannya, Ikuo Matsuda, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 2026
[XMEN disease diagnosed following persistent Epstein-Barr virus viremia and recurrent lymphadenopathy]Ryo Ikunari, Kyoko Yoshihara, Ikuo Matsuda, et al.
Journal of Molecular Biology|January 16, 2003
Purification, characterization, and gene expression of all sigma factors of RNA polymerase in a cyanobacteriumSousuke Imamura, Satoshi Yoshihara, Serina Nakano, et al.
European Radiology|March 23, 2019
Early evaluation of tumor response to <sup>90</sup>Y-ibritumomab radioimmunotherapy in relapsed/refractory B cell non-Hodgkin lymphoma: what is the optimal timing for FDG-PET/CT?Kazuhiro Kitajima, Masaya Okada, Toru Kashiwagi, et al.
Annals of Hematology|March 4, 2020
Treatment strategy in a patient showing borderline features between plasmablastic lymphoma and plasmablastic myeloma harboring a 17p deletionKyoko Yoshihara, Satoshi Yoshihara, Ikuo Matsuda, et al.
International Journal of Hematology|February 1, 2011
Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL geneMasaya Okada, Atsushi Satake, Katsuji Kaida, et al.
Pageof 15